Eli N. Glezer serves as Executive at Singular Genomics Systems, Inc., where they oversee executive responsibilities. Since joining the company, Eli N. Glezer has executed 11 insider transactions totaling $325.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 15, 2024 involved exercising options for 250 shares valued at $0.
Eli N. Glezer currently holds 154,333 shares of Singular Genomics Systems, Inc. (OMIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eli N. Glezer has been a net buyer of OMIC stock. They have purchased $325.4K and sold $0 worth of shares.
Eli N. Glezer's most recent insider trade was on Sep 15, 2024, when they sold 250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 500 |
| $N/A |
| Discretionary |
| Jun 15, 2024 | OMIC | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| May 9, 2024 | OMIC | $0 | Option Exercise | 15,000 | $N/A | Discretionary |
| Mar 15, 2024 | OMIC | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Dec 15, 2023 | OMIC | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Nov 16, 2023 | OMIC | $86.0K | Purchase | 200,000 | $0.43 | Discretionary |
| Sep 15, 2023 | OMIC | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Jun 15, 2023 | OMIC | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| May 17, 2023 | OMIC | $139.4K | Purchase | 170,000 | $0.82 | Discretionary |
| Dec 12, 2022 | OMIC | $100.0K | Purchase | 50,000 | $2.00 | Discretionary |